Slide background

Our success as a boutique advisory firm can be attributed to a consistent focus on select life science industry segments where we have developed domain expertise and an understanding of the innovative and disruptive trends impacting the competitive landscape of our clients. Our deal making ethos is based on more than 25 years of experience structuring and negotiating complicated cross border transactions

The CATALYSIS team embodies an entrepreneurial culture that stems from first-hand experience. Whether as an investor, board member or management executive of a life science start-up, we know the unique challenges inherent in the healthcare development life cycle.

Many of our clients are referred to us by former clients or themselves are repeat clients. We are extremely proud of this and see this as a testament to our commitment as well as consistency and thoughtfulness of the counsel we provide.

CATALYSIS is owned entirely by its partners. This clearly differentiates us from many of our industry peers which are part of larger financial institutions. Our independence enables us to provide clients with unbiased, “non-agenda” driven advice, without conflicts of interest.

About_BlueSq_pale   Preparing is key to every successful outcome; given our first-hand experience and understanding of what acquirers and investors expect, we are well versed at preparing management teams for an impending transaction or inflection point.

About_BlueSq_mid   Transacting can be disruptive to the day-to-day management of any company; our hands-on approach minimizes business disruptions and enables clients to focus on delivering consistent performance.

About_BlueSq_dark   Executing is a function of chemistry; clients have referred to us as ‘transaction-catalysts’ based on the transaction expertise and industry knowledge that the Catalysis team can bring to bear.

Mergers & Acquisitions

  • Leveraging our sector expertise and transaction track-record, we provide clients with tailored M&A solutions crafted to achieve optimal outcomes and maximise shareholder and stakeholder value.
  • Our understanding of the complexities involved in successfully executing cross-border transactions is reflected in the deals we have executed over the years.
  • We regularly advise on sell-side, spin-off and buy-side assignments.  Moreover, we have experience in the separation of assets as well as the bundling of associated intellectual property. 

    Past M&A transactions

Corporate Finance

  • Drawing on our domain expertise and industry insight, we guide clients on how to optimally articulate, differentiate and position their equity story.
  • We maintain a regular dialogue with specialist investors, which keeps us current on investment trends and particular investment areas of interest.
  • For placements to financial and corporate investors in Europe or the United Kingdom, we collaborate with European and/or UK-regulated specialist investment banks; similarly, for placements to financial and corporate investors in the United States, we collaborate with a US-regulated specialist investment banking boutique.

Strategic Advisory

  • Combining CATALYSIS’ industry expertise with the venture capital and operational background of the individual team members, we are ideally positioned to highlight future challenges that management teams are bound to encounter.  We provide versatile solutions and guidance on how clients may acheive and sustain their growth aspirations.
  • Whether a client is evaluating the merits of expanding into unchartered geographic territories or wishes to narrow its strategic focus by divesting or out-licensing non-core assets, CATALYSIS has the experience to formulate the requisite strategic roadmap.

© Copyright - CATALYSIS Capital Partners Limited